As of 2025-01-19, the Relative Valuation of Edwards Lifesciences Corp (EW) is 179.00 USD. This relative valuation is based on P/E multiples. With the latest stock price at 69.78 USD, the upside of Edwards Lifesciences Corp based on Relative Valuation is 156.5%.
The range of the Relative Valuation is 69.12 - 328.88 USD.
| Range | Selected | |
| Trailing P/E multiples | 33.9x - 46.6x | 40.8x |
| Forward P/E multiples | 29.0x - 35.7x | 29.6x |
| Fair Price | 69.12 - 328.88 | 179.00 |
| Upside | -0.9% - 371.3% | 156.5% |
| Date | P/E |
| 2025-01-17 | 9.90 |
| 2025-01-16 | 9.91 |
| 2025-01-15 | 9.97 |
| 2025-01-14 | 10.07 |
| 2025-01-13 | 10.08 |
| 2025-01-10 | 10.41 |
| 2025-01-08 | 10.52 |
| 2025-01-07 | 10.44 |
| 2025-01-06 | 10.43 |
| 2025-01-03 | 10.48 |
| 2025-01-02 | 10.29 |
| 2024-12-31 | 10.50 |
| 2024-12-30 | 10.53 |
| 2024-12-27 | 10.73 |
| 2024-12-26 | 10.77 |
| 2024-12-24 | 10.69 |
| 2024-12-23 | 10.61 |
| 2024-12-20 | 10.61 |
| 2024-12-19 | 10.48 |
| 2024-12-18 | 10.33 |
| 2024-12-17 | 10.51 |
| 2024-12-16 | 10.48 |
| 2024-12-13 | 10.40 |
| 2024-12-12 | 10.49 |
| 2024-12-11 | 10.47 |
| 2024-12-10 | 10.41 |
| 2024-12-09 | 10.05 |
| 2024-12-06 | 10.14 |
| 2024-12-05 | 10.27 |
| 2024-12-04 | 10.52 |
| 2024-12-03 | 9.96 |
| 2024-12-02 | 10.00 |
| 2024-11-29 | 10.12 |
| 2024-11-27 | 10.22 |
| 2024-11-26 | 10.15 |
| 2024-11-25 | 10.11 |
| 2024-11-22 | 10.00 |
| 2024-11-21 | 9.98 |
| 2024-11-20 | 9.86 |
| 2024-11-19 | 9.96 |
| 2024-11-18 | 9.91 |
| 2024-11-15 | 9.61 |
| 2024-11-14 | 9.38 |
| 2024-11-13 | 9.43 |
| 2024-11-12 | 9.33 |
| 2024-11-11 | 9.46 |
| 2024-11-08 | 9.39 |
| 2024-11-07 | 9.34 |
| 2024-11-06 | 9.32 |
| 2024-11-05 | 9.46 |